AIC
SGMO

Ameritas Investment Company’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Ameritas Investment Company’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-500
Closed -$5K – 1397
2019
Q3 		$5K Buy
+500
New +$5.61K ﹤0.01% 1297

Other funds holding SGMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameritas Investment Company's SGMO Position: Q4 2019 in Review

Ameritas Investment Company sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2019, closing a stake of 500 shares — an estimated $5K sold.

Ameritas Investment Company first reported a position in SGMO in Q3 2019 and held it in 1 quarter. The position peaked at $5K in Q3 2019. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2019.

  • Ameritas Investment Company reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 500 SANGAMO THERAPEUTICS INC shares in Q4 2019, an estimated $5K.
  • Ameritas Investment Company first reported a position in SANGAMO THERAPEUTICS INC in Q3 2019 and held it in 1 quarter.
  • Ameritas Investment Company's SANGAMO THERAPEUTICS INC position peaked at $5K in Q3 2019.
  • 193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2019.

Based on Ameritas Investment Company's 13F filing for Q4 2019, filed 18 Feb 2020.